{"id":4180,"date":"2025-03-10T09:54:34","date_gmt":"2025-03-10T08:54:34","guid":{"rendered":"https:\/\/www.pharmin.sk\/?p=4180"},"modified":"2025-03-10T09:58:59","modified_gmt":"2025-03-10T08:58:59","slug":"nove-pol-dnove-skolenie-zaklady-epidemiologie","status":"publish","type":"post","link":"https:\/\/www.pharmin.sk\/sk\/aktuality\/nove-pol-dnove-skolenie-zaklady-epidemiologie\/","title":{"rendered":"Nov\u00e9 pol-d\u0148ov\u00e9 \u0161kolenie: Z\u00e1klady epidemiol\u00f3gie"},"content":{"rendered":"<h3><strong>Pol-d\u0148ov\u00e9 \u0161kolenie<\/strong><\/h3>\n<h3><span style=\"color: #003366;\"><b>Z\u00e1klady epidemiol\u00f3gie a v\u00fdpo\u010det cie\u013eovej popul\u00e1cie pacientov pre \u00fa\u010dely farmako-ekonomick\u00fdch anal\u00fdz na Slovensku<\/b><\/span><\/h3>\n<p>Na \u0161kolen\u00ed v\u00e1m vysvetl\u00edme, ak\u00e9 s\u00fa\u00a0<strong>\u0161pecifik\u00e1 v\u00fdpo\u010dtu cie\u013eovej popul\u00e1cie pri r\u00f4znych ochoreniach<\/strong>. Je ur\u010den\u00e9 pre:<\/p>\n<ul>\n<li>pracovn\u00edkov farmaceutick\u00fdch spolo\u010dnost\u00ed (napr. medic\u00ednske, marketingov\u00e9 a Market Access oddelenia),<\/li>\n<li>pre odborn\u00edkov zo zdravotn\u00edckych in\u0161tit\u00faci\u00ed, ktor\u00ed potrebuj\u00fa lep\u0161ie porozumie\u0165 z\u00e1kladn\u00fdm epidemiologick\u00fdm ukazovate\u013eom a metodike v\u00fdpo\u010dtu ve\u013ekosti cie\u013eovej popul\u00e1cie vhodnej na lie\u010dbu liekmi.<\/li>\n<\/ul>\n<p>Uk\u00e1\u017eeme v\u00e1m, ako sa vysporiada\u0165 s metodick\u00fdmi po\u017eiadavkami, s probl\u00e9mom nedostupnosti d\u00e1t a pom\u00f4\u017eeme v\u00e1m porozumie\u0165 tomu, ako \u010do najobjekt\u00edvnej\u0161ie ur\u010di\u0165 ve\u013ekos\u0165 cie\u013eovej popul\u00e1cie a napredikova\u0165 jej v\u00fdvoj do \u010fal\u0161\u00edch rokov. Odprezentujeme v\u00e1m\u00a0<strong>ve\u013ea pr\u00edkladov z r\u00f4znych konan\u00ed o cene a \u00fahrade<\/strong>, ktor\u00e9 v\u00e1m ozrejmia o\u010dak\u00e1vania hodnotite\u013eov a regul\u00e1torov pri v\u00fdpo\u010dte cie\u013eovej popul\u00e1cie v konaniach o zara\u010fovan\u00ed nov\u00fdch liekov a indik\u00e1ci\u00ed do syst\u00e9mu \u00fahrad.<\/p>\n<p><b>R\u00e1mcov\u00fd program \u0161kolenia:<\/b><\/p>\n<ul>\n<li>Z\u00e1kladn\u00e9 epidemiologick\u00e9 pojmy<\/li>\n<li>Legislat\u00edvne a metodick\u00e9 po\u017eiadavky pre v\u00fdpo\u010det cie\u013eovej popul\u00e1cie<\/li>\n<li>Zdroje \u00fadajov pre \u00fa\u010dely v\u00fdpo\u010dtu cie\u013eovej popul\u00e1cie<\/li>\n<li>Postup pri v\u00fdpo\u010dte cie\u013eovej popul\u00e1cie<\/li>\n<li>Uk\u00e1\u017eky z hodnotiacej a rozhodovacej praxe<\/li>\n<\/ul>\n<p>Viac inform\u00e1ci\u00ed o\u00a0\u0161kolen\u00ed n\u00e1jdete na\u00a0<a href=\"https:\/\/www.pharmin.sk\/sk\/skolenia\/zaklady-epidemiologie\/\" data-auth=\"NotApplicable\" data-linkindex=\"3\"><u>na\u0161ej str\u00e1nke<\/u><\/a>.<\/p>\n<p><b>Ako sa prihl\u00e1si\u0165?<br \/>\n<\/b>Prihl\u00e1si\u0165 sa m\u00f4\u017eete jednoducho, bu\u010f priamo cez formul\u00e1r na na\u0161ej str\u00e1nke, alebo n\u00e1m nap\u00ed\u0161te na na\u0161u\u00a0<a href=\"mailto:pharmin@pharmin.sk\" data-linkindex=\"4\"><u>emailov\u00fa adresu<\/u><\/a>\u00a0a\u00a0my v\u00e1s budeme kontaktova\u0165.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pol-d\u0148ov\u00e9 \u0161kolenie Z\u00e1klady epidemiol\u00f3gie a v\u00fdpo\u010det cie\u013eovej popul\u00e1cie pacientov pre \u00fa\u010dely farmako-ekonomick\u00fdch anal\u00fdz na Slovensku Na \u0161kolen\u00ed v\u00e1m vysvetl\u00edme, ak\u00e9 s\u00fa\u00a0\u0161pecifik\u00e1 v\u00fdpo\u010dtu cie\u013eovej popul\u00e1cie pri r\u00f4znych ochoreniach. Je ur\u010den\u00e9 pre: pracovn\u00edkov farmaceutick\u00fdch spolo\u010dnost\u00ed (napr. medic\u00ednske, marketingov\u00e9 a Market Access oddelenia), pre odborn\u00edkov zo zdravotn\u00edckych in\u0161tit\u00faci\u00ed, ktor\u00ed potrebuj\u00fa lep\u0161ie porozumie\u0165 z\u00e1kladn\u00fdm epidemiologick\u00fdm ukazovate\u013eom a metodike v\u00fdpo\u010dtu<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-4180","post","type-post","status-publish","format-standard","hentry","category-aktuality"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/posts\/4180","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/comments?post=4180"}],"version-history":[{"count":0,"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/posts\/4180\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/media?parent=4180"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/categories?post=4180"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/tags?post=4180"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}